New Drugs Bringing New Challenges to AML: A Brief Review

The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeoh, Zhi Han, Bajel, Ashish, Wei, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537004/
https://www.ncbi.nlm.nih.gov/pubmed/34683144
http://dx.doi.org/10.3390/jpm11101003
Descripción
Sumario:The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel therapies on survival in AML and the challenges that ensue.

Ejemplares similares